KR20060121177A - 항종양 테르펜 화합물 - Google Patents

항종양 테르펜 화합물 Download PDF

Info

Publication number
KR20060121177A
KR20060121177A KR1020067011566A KR20067011566A KR20060121177A KR 20060121177 A KR20060121177 A KR 20060121177A KR 1020067011566 A KR1020067011566 A KR 1020067011566A KR 20067011566 A KR20067011566 A KR 20067011566A KR 20060121177 A KR20060121177 A KR 20060121177A
Authority
KR
South Korea
Prior art keywords
cancer
cells
compound
terpene
bisabolene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020067011566A
Other languages
English (en)
Korean (ko)
Inventor
아이포 델메 보웬
아쉼 야신 에이엘아이
Original Assignee
컴프톰 디벨로프먼츠 엘티디
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 컴프톰 디벨로프먼츠 엘티디 filed Critical 컴프톰 디벨로프먼츠 엘티디
Publication of KR20060121177A publication Critical patent/KR20060121177A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A61K31/015—Hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/01—Hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/32—Burseraceae (Frankincense family)
    • A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
KR1020067011566A 2003-11-13 2004-11-12 항종양 테르펜 화합물 Ceased KR20060121177A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0326518.8A GB0326518D0 (en) 2003-11-13 2003-11-13 Anti-cancer compounds
GB0326518.8 2003-11-13

Publications (1)

Publication Number Publication Date
KR20060121177A true KR20060121177A (ko) 2006-11-28

Family

ID=29726508

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020067011566A Ceased KR20060121177A (ko) 2003-11-13 2004-11-12 항종양 테르펜 화합물

Country Status (12)

Country Link
US (1) US20070259056A1 (https=)
EP (1) EP1682107B1 (https=)
JP (1) JP2007511492A (https=)
KR (1) KR20060121177A (https=)
CN (2) CN1882319B (https=)
AT (1) ATE439126T1 (https=)
AU (1) AU2004290946B2 (https=)
CA (1) CA2545717A1 (https=)
DE (1) DE602004022578D1 (https=)
DK (1) DK1682107T3 (https=)
GB (1) GB0326518D0 (https=)
WO (1) WO2005049001A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101849981B (zh) * 2010-06-22 2011-11-23 南京中医药大学 一种具有抗妇科肿瘤作用的没药有效部位及其制备方法和其应用
WO2012033634A2 (en) 2010-09-09 2012-03-15 Mary Kay Inc. Topical skin care formulations comprising plant extracts
WO2018144954A1 (en) * 2017-02-03 2018-08-09 City Of Hope Silica nanoparticle with an insoluble drug
WO2020033567A1 (en) * 2018-08-07 2020-02-13 University Of Florida Research Foundation Methods and compositions for substituted arylcycloheptane analogs
CN110960518B (zh) * 2019-12-31 2022-12-20 河南大学 金丝大菊提取物在制备抗肿瘤药物中的应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5190979A (en) * 1988-06-24 1993-03-02 Stephen Herman Ozonides of terpenes and their medical uses
US6350784B1 (en) * 1996-02-12 2002-02-26 Meryl J. Squires Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases
US5602184A (en) * 1993-03-03 1997-02-11 The United States Of America As Represented By Department Of Health And Human Services Monoterpenes, sesquiterpenes and diterpenes as cancer therapy
US5876728A (en) * 1995-02-15 1999-03-02 Howard David Kass Natural composition extracted from plants used in the treatment of cancer
AUPO316796A0 (en) * 1996-10-23 1996-11-14 Hood, John James David Essential oil
US6464839B1 (en) 1997-04-14 2002-10-15 Yuan Da International Group Limited Beta-elemene, method to prepare the same and uses thereof
US6265639B1 (en) * 1998-01-22 2001-07-24 Washington State University Foundation Gymnosperm nucleic acid molecules encoding sesquiterpene synthases and methods of use
FR2808196A1 (fr) 2000-04-27 2001-11-02 Andre Rougereau Nouveaux medicaments a base de melanges de sesquiterpenes
FR2811899B1 (fr) * 2000-07-20 2003-02-07 Anne Marie Pierrette Giraud Association d'huiles essentielles et applications therapeutiques
US6486706B2 (en) 2000-12-06 2002-11-26 Intel Corporation Domino logic with low-threshold NMOS pull-up
EP1351678A2 (en) * 2001-01-02 2003-10-15 Elizabeth Shanahan-Prendergast Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens
WO2002080951A1 (en) * 2001-04-06 2002-10-17 Synergistix Biotech, Inc. Herbal extracts for the treatment of cancer
GB0210152D0 (en) * 2002-05-02 2002-06-12 Compton Developments Ltd Use of plant materials
EP1587482A4 (en) * 2003-01-31 2010-08-25 Technion Res & Dev Foundation INFLAMMATORY COMPOSITIONS AND ITS USES
US20050074509A1 (en) * 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components

Also Published As

Publication number Publication date
DE602004022578D1 (de) 2009-09-24
EP1682107B1 (en) 2009-08-12
DK1682107T3 (da) 2009-12-14
AU2004290946B2 (en) 2010-04-22
WO2005049001A1 (en) 2005-06-02
CN1882319A (zh) 2006-12-20
US20070259056A1 (en) 2007-11-08
CN101862365A (zh) 2010-10-20
CN1882319B (zh) 2010-08-25
JP2007511492A (ja) 2007-05-10
ATE439126T1 (de) 2009-08-15
CA2545717A1 (en) 2005-06-02
AU2004290946A1 (en) 2005-06-02
GB0326518D0 (en) 2003-12-17
EP1682107A1 (en) 2006-07-26

Similar Documents

Publication Publication Date Title
Tsoyi et al. (+)-Nootkatone and (+)-valencene from rhizomes of Cyperus rotundus increase survival rates in septic mice due to heme oxygenase-1 induction
Hasanzadeh et al. Farnesiferol C induces cell cycle arrest and apoptosis mediated by oxidative stress in MCF-7 cell line
Namdeo et al. Therapeutic potential and novel formulations of ursolic acid and its derivatives: an updated review
Shahat et al. Phytochemical profiling, antioxidant and anticancer activities of Gastrocotyle hispida growing in Saudi Arabia
Sharma et al. Cytotoxic and apoptotic activity of essential oil from Ocimum viride towards COLO 205 cells
Mariadoss et al. Protective effects of [6]-paradol on histological lesions and immunohistochemical gene expression in DMBA induced hamster buccal pouch carcinogenesis
Indap et al. Anticancer activity of phenolic antioxidants against breast cancer cells and a spontaneous mammary tumor.
Balasenthil et al. Garlic induces apoptosis during 7, 12-dimethylbenz [a] anthracene-induced hamster buccal pouch carcinogenesis
da Silva Nascimento et al. Schinus terebinthifolius Raddi (Brazilian pepper) leaves extract: in vitro and in vivo evidence of anti-inflammatory and antioxidant properties
Banik et al. Natural Products as Anticancer Agents
Salama et al. GC–MS and Molecular Docking Analyses of Phytochemicals from Calendula officinalis L. Hexane Extract and Evaluation of its Antioxidant and Wound Healing Properties in Rats
Irshad et al. Chemical fingerprinting, antimicrobial, antioxidant, anti‐inflammatory, and anticancer potential of greenly synthesized silver nanoparticles from pistachio (Pistacia vera) nuts and senna (Cassia angustifolia Vahl.) leaves
KR20060121177A (ko) 항종양 테르펜 화합물
James et al. Formulation and Evaluation of Fumaria parviflora Loaded Oil in Water Emulsion-Based Cream.
Olutayo et al. The chemical composition of essential oil from the root of Cissampelos owariensis (p. beauv) and free radical scavenging activities of its extracts
Fahmy et al. Essential oil from Pelargonium graveolens shows anticancer activity and ameliorates the DNA damage and genotoxicity of doxorubicin in mice
EP1296700B1 (en) Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root
Obafemi et al. A review of plants with anticancer properties
Otitoju et al. Cytotoxic activity of Boswellia dalzielii (Hutch) stem bark extract against head and neck squamous cell carcinoma of the tongue (AW8507 cell line)
Akanksha et al. Rosmarinic acid: insights into analytical, pharmacological & pharmaceutical aspects
Malakotikhah et al. Investigating the Effect of Ferula assafoetida L. Extract and Farnesiferol on Adapter Activation and Inhibition of Metastasis of Genes Involved in the Severity of Malignancy in Breast Cancer Cell Lines
WO2009141645A1 (en) Cancer therapy
Muleya Evaluation of biological activities of nine anti-inflammatory medicinal plants and characterization of antimicrobial compounds from Pomaria sandersonii and Alepidea amatymbica
Syamsir Characterization of Compounds and Essential Oils from Curcuma Zedoaria, and Evaluation of Their Cytotoxic and Apoptotic Properties
KR20040058734A (ko) 세포사멸 유도작용을 갖는 후박나무 추출물

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20060612

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20091027

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20110527

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20111130

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20110527

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I